Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

930
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
930
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

486
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
486
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

838
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
838
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

536
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
536
Ventilatory Modes01:14

Ventilatory Modes

1.4K
Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension.

bioRxiv : the preprint server for biology·2026
Same author

Resolving Diagnostic Discordance in Group 2 Pulmonary Hypertension Through Staged Physiologic Testing: Insights From PVDOMICS.

medRxiv : the preprint server for health sciences·2026
Same author

Phenotypic Characterization of Unclassified Pulmonary Hypertension.

Circulation. Heart failure·2026
Same author

Metabolomic shifts in beef steers rotationally grazing toxic endophyte-infected tall fescue under fall conditions.

Frontiers in veterinary science·2026
Same author

Randomised, sham-controlled, double-blinded, multicentre international trial to evaluate the efficacy of the Ventfree Respiratory Muscle Stimulator to assist ventilator weaning in critically ill patients: a study protocol of a randomised controlled trial.

BMJ open·2026
Same author

Metabolomics of Right Ventricular Function in Pulmonary Hypertension.

Circulation research·2026

Related Experiment Video

Updated: Jan 24, 2026

Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs
04:10

Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs

Published on: March 8, 2024

1.8K

Noninvasive Ventilatory Support for Acute Hypercapnic Respiratory Failure.

Nicholas S Hill1, Giulia Spoletini2, Gregory Schumaker3

  • 1Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center, Boston, Massachusetts. nhill@tuftsmedicalcenter.org.

Respiratory Care
|May 22, 2019
PubMed
Summary

Noninvasive ventilation effectively treats hypercapnic respiratory failure in COPD patients, reducing mortality. High-flow nasal cannula shows promise as an alternative or adjunct therapy, though further research is needed.

Keywords:
COPDNIVacute hypercapnic respiratory failurehigh-flow nasal cannulanoninvasive ventilationventilatory modality

More Related Videos

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS
07:20

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

11.6K
Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns
08:34

Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns

Published on: September 16, 2019

12.1K

Related Experiment Videos

Last Updated: Jan 24, 2026

Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs
04:10

Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs

Published on: March 8, 2024

1.8K
Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS
07:20

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

11.6K
Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns
08:34

Investigation into Deep Breathing through Measurement of Ventilatory Parameters and Observation of Breathing Patterns

Published on: September 16, 2019

12.1K

Area of Science:

  • Pulmonology
  • Critical Care Medicine

Background:

  • Noninvasive ventilation (NIV) is a cornerstone treatment for acute hypercapnic respiratory failure (HCRF) in Chronic Obstructive Pulmonary Disease (COPD).
  • NIV improves dyspnea, gas exchange, and reduces mortality in COPD patients.
  • NIV is also beneficial in COPD with pneumonia, postextubation, postoperative, and do-not-intubate scenarios.

Purpose of the Study:

  • To review the established role of NIV in HCRF.
  • To explore the emerging use of high-flow nasal cannula (HFNC) in HCRF.
  • To compare the efficacy of HFNC with NIV in severe COPD.

Main Methods:

  • Literature review of studies on NIV and HFNC for HCRF.
  • Analysis of clinical outcomes including dyspnea, gas exchange, and mortality.
  • Evaluation of HFNC's role as an alternative or adjunct to NIV.

Main Results:

  • NIV is the primary choice for HCRF in COPD, improving outcomes and preventing intubation.
  • NIV benefits HCRF in various clinical settings beyond COPD.
  • HFNC demonstrates potential in oxygenation, ventilatory efficiency, and reducing work of breathing in severe COPD, with some patients benefiting from its use alone or with NIV.

Conclusions:

  • NIV remains a highly effective treatment for HCRF in COPD and other conditions.
  • HFNC is a promising ventilatory support technique for severe COPD with HCRF.
  • Further research is required to fully establish HFNC's role in HCRF management, particularly in comparison to NIV.